CATALOGO DEI PRODOTTI DELLA RICERCA

COLOMBATTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.976
EU - Europa 7.372
AS - Asia 5.267
SA - Sud America 738
AF - Africa 121
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.797
RU - Federazione Russa 2.387
GB - Regno Unito 2.217
SG - Singapore 2.195
CN - Cina 1.545
BR - Brasile 617
SE - Svezia 473
VN - Vietnam 435
HK - Hong Kong 434
IT - Italia 423
DE - Germania 375
FI - Finlandia 374
FR - Francia 352
IE - Irlanda 347
KR - Corea 161
UA - Ucraina 131
CA - Canada 105
IN - India 90
JP - Giappone 66
TR - Turchia 65
NL - Olanda 57
MX - Messico 50
BD - Bangladesh 47
AR - Argentina 46
BE - Belgio 45
ES - Italia 43
IQ - Iraq 37
ZA - Sudafrica 34
PL - Polonia 32
IR - Iran 29
NG - Nigeria 29
ID - Indonesia 25
AT - Austria 19
EC - Ecuador 16
PK - Pakistan 16
CO - Colombia 15
LT - Lituania 14
MA - Marocco 13
PH - Filippine 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
VE - Venezuela 12
AU - Australia 11
AE - Emirati Arabi Uniti 10
MY - Malesia 10
RO - Romania 10
CH - Svizzera 9
AZ - Azerbaigian 8
CL - Cile 8
EG - Egitto 8
UY - Uruguay 8
JO - Giordania 7
PT - Portogallo 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
GR - Grecia 6
HR - Croazia 6
KE - Kenya 6
NP - Nepal 6
PA - Panama 6
PE - Perù 6
PY - Paraguay 6
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
TW - Taiwan 5
AL - Albania 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
KW - Kuwait 4
LV - Lettonia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
CY - Cipro 2
GH - Ghana 2
GY - Guiana 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
OM - Oman 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
Totale 22.468
Salva come PNG Salva come JPEG
Città #
Southend 1.866
Singapore 1.197
Jacksonville 1.015
Ashburn 977
Chandler 875
Moscow 775
Dallas 760
Woodbridge 723
San Jose 633
Ann Arbor 489
Hong Kong 419
Dublin 347
Houston 269
Beijing 261
The Dalles 253
Verona 224
Los Angeles 214
Buffalo 175
Wilmington 150
New York 149
Ho Chi Minh City 138
Lawrence 132
Princeton 132
Jinan 122
Nanjing 112
Hanoi 103
Shenyang 101
Helsinki 99
Tianjin 80
Munich 67
Boardman 65
Hebei 64
São Paulo 59
Columbus 57
Tokyo 56
Seattle 53
Santa Clara 50
Orem 47
Brussels 45
Changsha 44
Milan 42
Sindelfingen 42
Zhengzhou 42
Montreal 39
Taizhou 37
Chennai 36
London 35
Ningbo 34
Cambridge 33
Hangzhou 32
Nanchang 32
Philadelphia 32
Fairfield 31
Guangzhou 31
San Francisco 31
Haikou 30
Jiaxing 30
Seoul 30
Turku 29
Amsterdam 28
Denver 28
Abuja 27
Falls Church 27
Warsaw 27
Norwalk 25
Frankfurt am Main 24
Johannesburg 24
Stockholm 24
Taiyuan 24
Brooklyn 23
Chicago 22
Da Nang 22
Fuzhou 22
Council Bluffs 20
Manchester 20
Redondo Beach 19
Atlanta 18
Auburn Hills 18
Lancaster 18
Rio de Janeiro 17
Falkenstein 15
Jakarta 15
Lanzhou 15
Belo Horizonte 14
Bologna 14
Boston 14
Haiphong 14
Phoenix 14
Poplar 14
Toronto 14
Barnet 13
Brasília 13
Mexico City 13
Biên Hòa 12
Montréal 12
Nuremberg 12
Paris 12
Redwood City 12
Rome 12
Detroit 11
Totale 14.787
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 294
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 292
Anti PSMA immunotoxins activity against prostate cancer cell lines. 287
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 282
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 271
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 252
Immunotoxins and other conjugates: preparation and general characteristics. 249
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 246
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 245
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 244
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 240
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 235
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 235
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 231
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 230
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 229
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 223
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 223
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 217
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 216
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 214
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 214
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 213
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 210
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 208
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 208
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 204
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 203
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 203
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 203
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 200
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 200
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 198
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 196
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 195
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 194
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 191
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 190
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 190
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 189
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 188
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 186
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 185
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 184
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 184
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 183
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 183
T cell immune function in newborn infants 181
Monoclonal antibodies against ricin: effects on toxin function 181
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 180
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 180
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 178
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 178
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 178
N-terminal deletion affetcs catalytic activity of saporin toxin. 176
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 176
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 175
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 175
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 175
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 175
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 175
Cloning and characterisation of canine prostate-specific membrane antigen 173
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 173
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 172
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 171
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 171
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 170
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 170
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 170
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 167
Problems and potentials in immunotoxin therapy 165
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 165
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 163
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 163
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 162
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 161
Sensitivity of human glioma cells to cytotoxic heteroconjugates 160
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 160
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 160
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 160
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 160
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 159
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 158
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 157
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 157
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 157
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 156
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 153
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 151
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 150
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 150
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 150
Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems. 150
Targeted Silica Nanoparticles for PhotoDynamic Therapy (PDT) 149
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 148
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 148
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 141
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 138
Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens 135
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 133
Totale 18.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.894
article - articoli 45.963
book - libri 0
conference - conferenze 15.982
curatela - curatele 0
other - altro 0
patent - brevetti 937
selected - selezionate 0
volume - volumi 2.012
Totale 129.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 0 0 0 0 13 191 54
2021/20221.157 111 308 6 99 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/20253.027 176 201 65 466 209 126 185 124 469 191 260 555
2025/20268.527 598 528 868 1.340 2.148 621 917 415 608 484 0 0
Totale 22.564